Clexane (enoxaparin) or Fragmin (dalteparin) as thrombolytics in hip surgery? Is Fragmin better than Clexane?
Abildgaard, U.; Sandset, P.M.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 116(19): 2351; Author Reply 2352
1996
ISSN/ISBN: 0029-2001 PMID: 8804214 Document Number: 455332
Document emailed within 1 workday
Related Documents
Brieger, D.; Dawes, J. 1994: Characterisation of persistent anti-Xa activity following administration of the low molecular weight heparin enoxaparin sodium (Clexane) Thrombosis and Haemostasis 72(2): 275-280Brieger, D.; Dawes, J. 1996: Long-term persistence of biological activity following administration of Enoxaparin sodium (clexane) is due to sequestration of antithrombin-binding low molecular weight fragments--comparison with unfractionated heparin Thrombosis and Haemostasis 75(5): 740-746
Jørgensen, P.S.; Knudsen, J.B.; Broeng, L.; Josephsen, I.L.; Bjerregaard, P.; Hagen, K.K.; Jørgensen, P.K.; Tørholm, C. 1993: The thromboprophylactic effect of low molecular weight heparin (Fragmin) in hip fracture surgery. a placebo controlled trial Ugeskrift for Laeger 155(10): 706-708
Mishalov, V.G.; Litvinova, N.I.; Seliuk, V.M.; Cherniak, V.A. 2001: Application of clexane in reconstructive surgery of the aorta arch vessels for the arterial thrombosis prophylaxis Klinichna Khirurhiia 9: 12-14
Farkas, E.; Péley, Gábor.; Mátrai, Zán.; Rényi-Vámos, F.; Köves, Ián. 2005: Administration of clexane 4000 U/0.4 ml (40 mg) for preventing venous thromboembolic complications in patients undergoing surgery for malignant tumors. A follow-up study Magyar Sebeszet 58(3): 197-200
Nesvold, A.; Ly, B.; Abildgaard, U.; Stiris, M. 1991: Treatment of deep venous thrombosis with low molecular weight heparin (Fragmin) Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(27): 3296-3297
Kirienko, A.I.; Zolotukhin, I.A. 1998: Clexane in prevention of acute venous thrombosis and pulmonary thromboembolism Terapevticheskii Arkhiv 70(11): 78-80
Zemskov, V.S.; Kriuchina, E.A.; Koval'skaia, I.A. 2001: The influence of clexane on the fibronectin content in the blood plasma in patients with destructive pancreatitis Klinichna Khirurhiia 3: 15-18
Bratt, G.; Aberg, W.; Johansson, M.; Törnebohm, E.; Granqvist, S.; Lockner, D. 1990: Two daily subcutaneous injections of fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT) Thrombosis and Haemostasis 64(4): 506-510
Nesvold, A.; Kontny, F.; Abildgaard, U.; Dale, J. 1991: Safety of high doses of low molecular weight heparin (Fragmin) in acute myocardial infarction. a dose-finding study Thrombosis Research 64(5): 579-587
Planes, A.; Vochelle, N.; Bouthier, J.; Fagola, M.; Bellaud, M. 1991: Use of enoxaparin, a low molecular weight heparin, in elective hip surgery Seminars in Thrombosis and Hemostasis 17(Suppl 3): 296-303
Samama, M.; Combe-Tamzali, S. 1989: Prevention of thromboembolic disease in general surgery with enoxaparin British Journal of Clinical Practice. Supplement 65: 9
Haas, S.; Flosbach, C.W. 1993: Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial Seminars in Thrombosis and Hemostasis 19 Suppl. 1: 164-173
Bergmann, J.F.; Neuhart, E. 1996: A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group Thrombosis and Haemostasis 76(4): 529-534
Wiig, J.N.; Solhaug, J.H.; Bilberg, T.; Bjerkeset, T.; Edwin, B.; Grüner, O.P.; Havig, O.; Holter, O.; Knudsen, G.; Lundblad, R. 1995: Prophylaxis of venographically diagnosed deep vein thrombosis in gastrointestinal surgery. Multicentre trials 20 mg and 40 mg enoxaparin versus dextran European Journal of Surgery 161(9): 663-668
Turpie, A.G.G.; Bauer, K.A.; Eriksson, B.I.; Lassen, M.R. 2002: Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies Archives of Internal Medicine 162(16): 1833-1840
Akanmu, A.S.; Nnodu, O.E.; Giwa, S.O.; Salako, L.A.; Akinsete, I.; Adebule, G.T.; Adekoya-Cole, T.O.; Odunubi, O.O. 2004: Efficacy and safety of enoxaparin, a low molecular weight heparin in the prevention of deep vein thrombosis in Nigerian patients after orthopaedic surgery African Journal of Medicine and Medical Sciences 33(4): 335-340
Wojczuk, J. 1974: Treatment of thromboembolic conditions with thrombolytics and anticoagulants Wiadomosci Lekarskie 27(10): 877-882
Handler, J.A.; Feied, C.F. 1995: Acute pulmonary embolism. Aggressive therapy with anticoagulants and thrombolytics Postgraduate Medicine 97(1): 61
Hovland, A.; Nielsen, E.W. 2000: Check list in the treatment of acute myocardial infarction with thrombolytics and other drugs Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(13): 1580